company background image
600781 logo

FUREN Group PharmaceuticalLtd SHSE:600781 Stock Report

Last Price

CN¥0.77

Market Cap

CN¥482.9m

7D

0%

1Y

n/a

Updated

28 Jun, 2023

Data

Company Financials

FUREN Group Pharmaceutical Co.,Ltd.

SHSE:600781 Stock Report

Market Cap: CN¥482.9m

600781 Stock Overview

FUREN Group Pharmaceutical Co., Ltd. primarily engages in the manufacture and distribution of pharmaceuticals in Henan Province and Shanghai, China. More details

600781 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

FUREN Group Pharmaceutical Co.,Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for FUREN Group PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥0.77
52 Week HighCN¥3.65
52 Week LowCN¥0.51
Beta0.61
1 Month Change-8.33%
3 Month Change-34.19%
1 Year Changen/a
3 Year Change-79.30%
5 Year Change-95.02%
Change since IPO-66.52%

Recent News & Updates

Recent updates

Shareholder Returns

600781CN PharmaceuticalsCN Market
7D0%-1.9%-1.2%
1Yn/a-1.8%11.8%

Return vs Industry: Insufficient data to determine how 600781 performed against the CN Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 600781 performed against the CN Market.

Price Volatility

Is 600781's price volatile compared to industry and market?
600781 volatility
600781 Average Weekly Movement16.5%
Pharmaceuticals Industry Average Movement7.4%
Market Average Movement8.7%
10% most volatile stocks in CN Market12.8%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 600781's share price has been volatile over the past 3 months.

Volatility Over Time: 600781's weekly volatility has increased from 10% to 17% over the past year.

About the Company

FoundedEmployeesCEOWebsite
19962,916n/awww.shfuren.cn

FUREN Group Pharmaceutical Co., Ltd. primarily engages in the manufacture and distribution of pharmaceuticals in Henan Province and Shanghai, China. The company produces traditional Chinese medicines, such as capsules, tablets, granules, injections, eye drops, oral liquids, cream, and others. The company was formerly known Shanghai Minfeng Industrial (Group) Co., Ltd.

FUREN Group Pharmaceutical Co.,Ltd. Fundamentals Summary

How do FUREN Group PharmaceuticalLtd's earnings and revenue compare to its market cap?
600781 fundamental statistics
Market capCN¥482.91m
Earnings (TTM)-CN¥2.75b
Revenue (TTM)CN¥1.58b

0.3x

P/S Ratio

-0.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600781 income statement (TTM)
RevenueCN¥1.58b
Cost of RevenueCN¥783.59m
Gross ProfitCN¥798.23m
Other ExpensesCN¥3.55b
Earnings-CN¥2.75b

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-4.39
Gross Margin50.46%
Net Profit Margin-174.14%
Debt/Equity Ratio-144.8%

How did 600781 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/06/28 12:41
End of Day Share Price 2023/06/19 00:00
Earnings2023/03/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

FUREN Group Pharmaceutical Co.,Ltd. is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shuchang LiuChangjiang Securities Co. LTD.